Scalper1 News
Generic-drug giant Mylan (MYL) on Friday lost out in a takeover bid for Swedish counterpart Meda, but its stock was still up more than 4% in midday trading on the stock market. Late Thursday, Britain’s Financial Times reported that Mylan and Meda were in talks. It didn’t say exactly what Mylan bid, but said it was a “significant premium” to Meda’s market cap of $4.5 billion. Meda is traded on the Stockholm exchange. Citi analyst Liav Abraham was Scalper1 News
Scalper1 News